Rchr
J-GLOBAL ID:200901057847142219   Update date: Jul. 23, 2022

Katoh Masaru

カトウ マサル | Katoh Masaru
Affiliation and department:
Job title: Chief
Homepage URL  (1): http://www.ncc.go.jp/en/ri/department/omics_network/index.html
Research field  (3): Information networks ,  Tumor biology ,  Internal medicine - General
Research keywords  (5): Molecular Medicine ,  Notch ,  Hedgehog ,  FGF ,  WNT
Research theme for competitive and other funds  (5):
  • 2017 - 2026 Knowledge Base Project (2)
  • 2012 - 2016 Knowledge Base Project (1)
  • 2007 - 2011 Stem-Cell Signaling Network Project
  • 2003 - 2006 Post-WNTome Project
  • 1998 - 2002 Human WNTome Project
Papers (115):
  • Masaru Katoh. Fibroblast growth factor receptors as treatment targets in clinical oncology. Nature Reviews Clinical Oncology. 2019. 16. 105-122
  • Masaru Katoh. Combination immuno-oncology therapy with immune checkpoint blockers targeting PD-L1, PD-1 or CTLA4 and epigenetic drugs targeting MYC and immune evasion for precision medicine. Journal of Thoracic Disease. 2018. 10. 3. 1294-1299
  • Masaru Katoh. Multi-layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β-catenin signaling activation. Int J Mol Med. 2018. 42. 713-725
  • Masaru Katoh. Combination immuno-oncology therapy with pembrolizumab, an anti-PD-1 monoclonal antibody targeting immune evasion, and standard chemotherapy for patients with the squamous and non- squamous subtypes of non-small cell lung cancer. J Thorac Dis. 2018. 10. 5178-5183
  • Masaru Katoh. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review). INTERNATIONAL JOURNAL OF ONCOLOGY. 2017. 51. 5. 1357-1369
more...
Lectures and oral presentations  (20):
  • Genomics and genetics of human gastric cancer
    (20th International Congress of Genetics: Understanding Living Systems (Berlin, Germany) 2008)
  • Genomics and genetics of human gastric cancer
    (20th International Congress of Genetics: Understanding Living Systems (Berlin, Germany) 2008)
  • WNT signaling pathway and stem cell signaling network
    (1st International Conference on Nutrition and Intestinal Health (Kaiserslautern, Germany) 2007)
  • Comparative integromics on bHLH transcription factors with Orange domain
    (4th International Symposium on Basic Helix-Loop-Helix Genes: Development and Diseases (Kyoto, Japan) 2007)
  • Comparative integromics on WNT signaling pathway
    (Gordon Research Conference on Cell Contact and Adhesion (Lucca, Italy) 2007)
more...
Education (5):
  • 1993 - PhD, Graduate School of Medicine, The University of Tokyo
  • 1986 - The University of Tokyo Faculty of Medicine School of Medicine
  • 1986 - MD, Faculty of Medicine, The University of Tokyo
  • 1980 - 東京大学 理科 III 類 再入学し、2度目の入学式に出席
  • 1979 - 東京大学 理科 I 類 入学するも、中途退学
Professional career (2):
  • MD (The University of Tokyo)
  • PhD (The University of Tokyo)
Work history (11):
  • 2014 - Chief, Department of Omics Network, National Cancer Center (~ 2021.03)
  • 1998 - 国立がんセンター 細胞遺伝研究室長
  • 1998 - Chief, Genetics and Cell Biology Scetion, National Cancer Center
  • 1996 - 米国 NIH Varmus Laboratory ポスドク
  • 1996 - Adjunct Scientist, Varmus Laboratory, NIH, USA
Show all
Committee career (6):
  • 2014/06 - 現在 International Expert Panel, Singapore NMRC
  • 2014/06 - 現在 シンガポール国立医療研究審議会 国際専門委員
  • 2013/10 - 現在 Chief Editor, Frontiers in Molecular Medicine
  • 2013/10 - 現在 Frontiers in Molecular Medicine 編集長
  • 2011/01 - 現在 Academic Editor, PLoS ONE
Show all
Awards (2):
  • 2005 - HGNC Prize at HGM2005
  • 2005 - HGNC Prize at HGM2005
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page